Melissa Molina Madrid, PA
Physician Assistant · Orlando, FLNPI 1093366486
Payments from drug & device makers
Across 47 payments — averaging $20.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$167
- Neurocrine Biosciences, Inc.$89
- Lilly USA, LLC$74
- AstraZeneca$66
- Exact Sciences$66
- Johnson & Johnson$61
- plus $459 from 15 others
What the payments were for
- Food & beverage$982100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 7 | $167 |
| Neurocrine Biosciences, Inc. | 4 | $89 |
| Lilly USA, LLC | 4 | $74 |
| AstraZeneca | 4 | $66 |
| Exact Sciences | 4 | $66 |
| Johnson & Johnson | 3 | $61 |
| AbbVie | 3 | $57 |
| Vanda Pharmaceuticals Inc. | 3 | $53 |
| Gilead | 1 | $50 |
| Chiesi USA, Inc. | 1 | $49 |
| Pfizer | 2 | $37 |
| Biohaven Pharmaceuticals, Inc. | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Luye Pharma (USA) Ltd. | 1 | $26 |
| Tris Pharma Inc | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| GSK | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Merck | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $13 |
How this compares
$982 in reported general payments places this provider in the 60th percentile of 8,062 physician assistant providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 11 | $256 |
| Rosuvastatin Calcium | 12 | $113 |
| Metformin Hcl | 12 | $105 |
| Atorvastatin Calcium | 16 | $99 |
| Levothyroxine Sodium | 11 | $97 |
| Methylprednisolone | 12 | $93 |
| Fluticasone Propionate | 13 | $86 |
| Losartan Potassium | 15 | $77 |
| Amlodipine Besylate | 14 | $68 |
| Lisinopril | 12 | $47 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Orlando
- Risha BellomoOrlando$397K
- Nicole HillOrlando$319K
- Gina ManginOrlando$300K
- Brandon NievesOrlando$235K
- Nancy MimbsOrlando$118K
- Daniel HendricksOrlando$53K
- Richard MarshallPort Orange$988K
- Audrey BeckerSt Augustine$689K
- Kevin WilliamsTampa$647K
- Brian BonomoLecanto$559K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.